New York City in March is a study in contrasts. Outside, the weather oscillates between brisk winter winds and the teasing warmth of early spring. Inside the gilded lobbies of the Lotte New York Palace and the InterContinental Barclay, however, the atmosphere is singular and constant: electric, high-stakes, and relentlessly focused.
This is the setting for DCAT Week, the premier annual event for companies engaged in the global bio/pharmaceutical manufacturing value chain. If you work in pharmaceutical development, sourcing, procurement, or manufacturing, this week is likely the anchor of your entire Q1 schedule.
With DCAT 2026 fast approaching, this comprehensive guide will walk you through everything you need to know.
What is the DCAT Conference?
At its core, DCAT Week is the flagship event of the DCAT organization. Unlike broad scientific congresses or massive trade expos like CPHI, DCAT Week is a niche, high-value gathering designed specifically for the business side of the pharma industry.
Held annually in New York City, it brings together the decision-makers who control the pharmaceutical supply chain. This includes the buyers (procurement and sourcing executives from big pharma and biotech) and the sellers (Contract Development and Manufacturing Organizations, or CDMOs, and suppliers of active ingredients and chemicals).
The event is unique because it is decentralized. Rather than taking place in a single convention center like the Javits, it takes over the meeting spaces, suites, and ballrooms of several official “DCAT Hotels” in Midtown Manhattan. For one week, a few city blocks become the global headquarters of the pharmaceutical manufacturing industry.
The “No Trade Show” Model: How It Works
The most critical distinction to grasp about DCAT Week is that it is not a trade show.
If you arrive expecting to walk a floor and browse vendor capabilities, you will be disappointed. There is no expo hall. Instead, the “booths” are private hotel suites and dedicated business meeting rooms.
This structure dictates the flow of the event. It is designed entirely around pre-scheduled, private meetings. A typical attendee—say, a Global Category Manager for a major pharmaceutical company—might have a schedule that looks like a corporate marathon:
- 8:00 AM: Breakfast meeting with a key API supplier at the Lotte Palace.
- 9:30 AM: Strategic review with a sterile fill-finish partner at the InterContinental Barclay.
- 11:00 AM: Internal team debrief in a hotel lobby.
- 12:30 PM: Lunch negotiation with a packaging vendor at a nearby steakhouse.
This model serves a specific purpose: efficiency. The goal is to condense a year’s worth of travel and supplier audits into four intense days. Senior executives attend because the ROI on their time is undeniable. They can meet the leadership teams of their top 10 strategic partners without ever leaving a three-block radius.
Key Themes Driving the Conversation at DCAT 2026
While the private meetings are where the deals are signed, the educational sessions at DCAT Week provide the context for those deals. The content is curated by industry volunteers and focuses on the macro-trends shaping the market.
For the upcoming conference, several themes are expected to dominate both the stage and the suites:
1. The “BioSecure” Era and Geopolitical De-Risking
Supply chain resilience is no longer just a buzzword; it is a regulatory imperative. With legislation like the BIOSECURE Act looming, companies are actively looking to diversify their supply chains. Discussions will focus heavily on “China-plus-one” strategies, friend-shoring, and the rise of manufacturing hubs in India and Europe. Buyers are not just looking for capacity; they are looking for geopolitical stability.
2. The Capacity Crunch: GLP-1s and ADCs
The pharmaceutical landscape is currently being reshaped by the explosive demand for GLP-1 agonists (obesity and diabetes drugs) and Antibody-Drug Conjugates (ADCs). These modalities require specialized manufacturing capacity—specifically in sterile fill-finish and high-potency handling—that is in short supply. DCAT Week is where buyers will be fighting to reserve future production slots, turning capacity into a seller’s market.
3. Sustainability as a Deal-Breaker
Scope 3 emissions targets are trickling down from corporate pledges to procurement mandates. Suppliers at DCAT Week will find themselves fielding detailed questions about their carbon footprints, energy sources, and green chemistry initiatives. Sustainability is moving from a “nice-to-have” slide in a pitch deck to a “license-to-operate” requirement in the contract.
Who Attends DCAT?
The attendee list reads like a “who’s who” of the industry. Because of the high-level nature of the meetings, companies typically send their senior leadership. You will see:
- C-Suite Executives: CEOs and Presidents of CDMOs and chemical companies.
- Sourcing & Procurement Leaders: The individuals holding the checkbooks for external manufacturing.
- Business Development VPs: The sales leaders responsible for securing long-term partnerships.
- Supply Chain Strategists: Experts focused on logistics, risk management, and continuity.
This seniority creates a unique atmosphere. The conversations are strategic rather than tactical. You aren’t just discussing the price of a raw material; you are discussing five-year strategic alignments and joint capital investments.
Meet the Experts: The DCAT Week Speaker Lineup
Beyond the private negotiations, DCAT Week offers a rare opportunity to hear directly from the industry’s most influential voices. This year’s educational programs feature a mix of data analysts, investment bankers, and senior executives from top-tier pharma and supplier companies.
Here is a breakdown of the confirmed speakers and panelists, organized by session, and what they will be discussing.
1. The Pharma Industry Outlook (Market Trends & Data)
Focus: Global growth, drug pricing reforms, and the impact of trade policy on R&D.
- Graham Lewis
- Vice President, Global Pharma Strategy, IQVIA
- The Insight: As a leading strategist at IQVIA, Graham will break down the “uncertain environment” facing the industry, focusing on regional growth in both developed and emerging markets.
- Murray Aitken
- Senior Vice President, IQVIA and Executive Director, The IQVIA Institute for Human Data Science
- The Insight: Murray will provide the data-driven backbone of the session, offering projections on innovator vs. generic growth and the performance of leading therapeutic sectors.
2. Manufacturing Investments & Financial Outlook
Focus: US capacity expansion, geographic shifts, and the financial health of the CDMO sector.
- Sean P. McKee
- Partner, PharmaBioSource
- The Insight: Sean will address the headlines regarding US-based manufacturing. He will provide a reality check on whether announced investments are actually translating into operational capacity shifts.
- Daniel Cohen
- Managing Director and Global Head of Pharma Outsourcing Investment Banking, Morgan Stanley
- The Insight: Providing the Wall Street perspective, Daniel will cover valuations, deal-making trends, and the macro fundamentals currently driving the pharmaceutical outsourcing sector.
3. Panel: Future-Proofing the Customer–Supplier Relationship
Focus: Risk management, supply chain resilience, and navigating complexity through collaboration.
The Moderator:
- Vishal Bhandari – Partner, Healthcare & Life Sciences Practice, Americas, Kearney
The Panelists:
- Xavier De Ceuninck – Category Management Lead, PGS Global Procurement, Pfizer
- Emad Abdelsadek – Vice President, Sales, EMEA, BD Biopharma Systems
- Troy Mathews – Executive Director, Direct Materials Strategic Sourcing, Bristol Myers Squibb
- Sara Henneman – Vice President and General Manager, Cell Culture and Cell Therapy, Thermo Fisher Scientific
The Discussion: This powerhouse panel combines the “Buy Side” (Pfizer, BMS) and the “Sell Side” (BD, Thermo Fisher). They will debate how to move beyond transactional relationships to true partnerships that can withstand tariff changes and supply chain shocks.
4. AI & Digitalization in Sourcing
Focus: Separating the hype from the reality of AI in procurement and supply management.
The Expert Analyst:
- Corwin Hee
- Senior Director Analyst, Healthcare and Life Sciences Practice, Gartner
- The Insight: Corwin will provide an objective assessment of where AI currently stands in the supply chain, outlining the timeline for adoption and specific use-cases.
The Industry Panel:
- Christina da Cunha – Head of CMO Operations and Business Transformation, Sanofi
- Bala Sreenivasan – Senior Vice President, Global Supply and Value Chain Management, Merck & Co. Inc.
- Janel Firestein (Moderator) – Partner and Life Sciences Practice Leader, Clarkston Consulting
The Discussion: Senior executives from Sanofi and Merck will share candid case studies on how their companies are actually using AI for supplier selection and visibility today—and what they expect their suppliers to adopt in the near future.
5. Creating Value Beyond Product and Price
Focus: Defining “value” in a cost-constrained market and aligning buyer/seller expectations.
The Session Overview: While the previous sessions focus on hard data and digital tools, this session tackles the subjective but crucial friction point in the industry: Value vs. Cost.
Bio/pharma companies are demanding innovation and “value-added” services from their suppliers, but they are often hesitant to pay for them. Conversely, suppliers (CDMOs) need to know which investments will actually yield a return. This session features an executive panel that will debate:
- The Disconnect: Do buyers and sellers actually agree on what “value creation” means?
- The Bill: Who absorbs the cost for innovation—the innovator or the manufacturer?
- The Metric: How do procurement teams formally evaluate “value-add” during the RFP process?
Exclusive Insight:
- The DCAT Benchmarking Study: This session will also reveal the findings of a new industry study titled “Creating Value Beyond Product and Price in the Pharma Customer–Supplier Relationship.” This report (released March 2026) provides rare data on how the industry quantifies intangibles like service, speed, and technical support.
The Grand Finale: The Annual Dinner
The week culminates on Thursday night with the DCAT Annual Dinner. This is not your standard rubber-chicken conference banquet. It is a black-tie gala that is one of the most prestigious social events in the industry.
Held in a massive ballroom, it hosts thousands of guests and typically features a keynote speaker of global renown—past speakers have included heavyweights like Will Smith, George W. Bush, and Tony Blair. It is a night for celebrating the industry, cementing relationships forged during the week, and exhaling after four days of intense negotiation.
FAQ: Everything You Need to Know About DCAT
If you are prepping for your trip or trying to explain the event to a colleague, here are the answers to the most common questions.
1. What does DCAT stand for?
DCAT stands for the Drug, Chemical & Associated Technologies Association. Founded in 1890, it is a not-for-profit, member-supported global business development association. While the name reflects its historical roots, today it primarily serves the bio/pharmaceutical manufacturing value chain.
2. What is the purpose of DCAT Week?
The primary purpose is business development and relationship management. Unlike scientific conferences focused on R&D data, DCAT Week is focused on the business of making drugs.
- For Buyers (Pharma/Biotech): It is about securing supply chains, negotiating contracts, and vetting new partners.
- For Suppliers (CDMOs/Ingredient Mfrs): It is about meeting existing clients to renew agreements and finding new customers.
- For Everyone: It provides critical market intelligence through educational sessions and peer networking.
3. Is DCAT Week only for members?
Yes and No.
- Registration & Badges: Official registration for the event—which grants access to the Member Lounges, educational sessions, networking receptions, and the Annual Dinner—is strictly exclusive to employees of DCAT Member Companies. Your company must be a paying member of the association for you to register.
- Attending Meetings: However, because meetings are private, non-member companies (such as prospective clients) can physically attend meetings if they are invited by a Member Company into their private suite. But without a badge, these non-members cannot access the lounges, official transportation, or DCAT-sponsored events.
4. What is the dress code for DCAT Week?
The dress code splits into two distinct categories:
- Daytime (Monday – Thursday): The standard is Business Professional. This means suits, blazers, ties, and professional dresses. This is a senior-executive level event, and the attire reflects that. Business Casual is becoming slightly more common, but “smart” is the operative word. You want to look ready to sign a contract.
- Thursday Night (The Annual Dinner): The Annual Dinner is a strict Black Tie event. This means tuxedos for men (not just a dark suit) and evening gowns or cocktail attire for women. It is a formal, glitzy affair, so dress to impress.
5. Where exactly does the conference take place?
DCAT Week does not use a convention center. It takes place across several Official DCAT Week Hotels in Midtown Manhattan. Historically, the headquarters hotel is the Lotte New York Palace on Madison Avenue. Other key venues often include the InterContinental New York Barclay, the Lotte, and increasingly other nearby luxury hotels.
- Note: Always check your specific meeting invites for the location. “Suite 1402” could be in any of three different hotels!
6. How do I schedule meetings if there are no booths?
You must be proactive. The DCAT organization provides a Member Company Directory to registered attendees. You (or your scheduler) need to reach out to the companies you want to meet with weeks or months in advance to request a time slot.
- Warning: The prime meeting slots (Tuesday/Wednesday mid-day) fill up 3-4 months out. If you wait until two weeks before the event, you will likely be meeting people at 7:00 AM or 6:00 PM.
7. Is there an app for the event?
Yes. The DCAT Week Mobile App is an essential tool for registered attendees. It contains the schedule of educational programs, the attendee directory, maps of the hotel layouts (crucial for finding meeting rooms), and alerts about networking events.
Final Thoughts on DCAT 2026:
DCAT Week is more than just a conference; it is the circulatory system of the pharmaceutical industry. It is where the agreements are made that ensure life-saving medicines can be manufactured and delivered to patients around the world. It is intense, exhausting, and often overwhelming for first-timers, but with the right preparation, it is also the most productive week of the year.
Pack your business cards, polish your shoes, and prepare for the Midtown Shuffle. We’ll see you in New York!
Feel free to schedule a meeting with us by clicking this link.
Senior Consultant, Process Development & CMC
